Aljawharah Alrubayyi

InstitutionUniversity of Oxford
AddressOxford
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in December 2020
    All Publications
    Bar chart showing 12 publications over 4 distinct years, with a maximum of 6 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Touizer E, Alrubayyi A, Rees-Spear C, Fisher-Pearson N, Griffith SA, Muir L, Pellegrino P, Waters L, Burns F, Kinloch S, Rowland-Jones S, Gupta RK, Gilson R, Peppa D, McCoy LE. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318. PMID: 34087093.
      Citations: 4     Fields:    Translation:HumansCells
    2. Alrubayyi A, Peppa D. Seeing SARS-CoV-2 variants through the eyes of T cells. Nat Rev Immunol. 2021 05; 21(5):274. PMID: 33854230.
      Citations: 2     Fields:    
    3. Richter FC, Alrubayyi A, Teijeira Crespo A, Hulin-Curtis S. Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review. Oxf Open Immunol. 2021; 2(1):iqab001. PMID: 34192269.
      Citations: 1     
    4. Alrubayyi A. B cell persistence and evolution to SARS-CoV-2. Nat Rev Immunol. 2021 01; 21(1):3. PMID: 33262448.
      Citations:    Fields:    
    5. Coveney C, Tellier M, Lu F, Maleki-Toyserkani S, Jones R, Bart VMT, Pring E, Alrubayyi A, Richter FC, Scourfield DO, Rehwinkel J, Rodrigues PRS, Davies LC, Gea-Mallorquí E. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion. Oxf Open Immunol. 2020; 1(1):iqaa004. PMID: 34192267.
      Citations: 1     
    6. Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, Lu F, Tellier M, Maleki-Toyserkani S, Richter FC, Scourfield DO, Gea-Mallorquí E, Davies LC. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology. Oxf Open Immunol. 2020; 1(1):iqaa005. PMID: 34192268.
      Citations: 4     
    7. Alrubayyi A. Intestinal attenuation of COVID-19 inflammation. Nat Rev Immunol. 2020 12; 20(12):719. PMID: 33051609.
      Citations:    Fields:    
    8. Alrubayyi A. Coordinated and sustained immune memory responses after mild COVID-19. Nat Rev Immunol. 2020 11; 20(11):648. PMID: 32895513.
      Citations:    Fields:    
    9. Alrubayyi A. NK cells in COVID-19: protectors or opponents? Nat Rev Immunol. 2020 09; 20(9):520. PMID: 32732951.
      Citations: 5     Fields:    
    10. Alrubayyi A. Publisher Correction: NK cells in COVID-19: protectors or opponents? Nat Rev Immunol. 2020 09; 20(9):579. PMID: 32753763.
      Citations:    Fields: